{"id":"https://openalex.org/W2028092672","doi":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","title":"Effects of exenatide twice daily versus sitagliptin on 24\u2010h glucose, glucoregulatory and hormonal measures: a randomized, double\u2010blind, crossover study","display_name":"Effects of exenatide twice daily versus sitagliptin on 24\u2010h glucose, glucoregulatory and hormonal measures: a randomized, double\u2010blind, crossover study","alternate_titles":[],"publication_year":2011,"publication_date":"2011-09-28","ids":{"openalex":"https://openalex.org/W2028092672","doi":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","mag":"2028092672","pmid":"https://pubmed.ncbi.nlm.nih.gov/21615670","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3258427"},"language":"en","primary_location":{"id":"doi:10.1111/j.1463-1326.2011.01428.x","doi":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2011.01428.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2028092672"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2011.01428.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074240559","display_name":"Jolene Kay Berg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"J. K. Berg","raw_affiliation_strings":["Cetero Research, San Antonio, TX, USA. jolene.berg@cetero.com","Cetero Research, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cetero Research, San Antonio, TX, USA. jolene.berg@cetero.com","institution_ids":[]},{"raw_affiliation_string":"Cetero Research, San Antonio, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042251550","display_name":"Sylvia K Shenouda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. K. Shenouda","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084630296","display_name":"Cory R. Heilmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. R. Heilmann","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. L. Gray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. L. Gray","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111629900","display_name":"J H Holcombe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. H. Holcombe","raw_affiliation_strings":["Lilly USA, LLC, Indianapolis, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly USA, LLC, Indianapolis, IN, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5074240559"],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":6.2011,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.97026406,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"13","issue":"11","first_page":"982","last_page":"989"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9210000038146973},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9769999980926514},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6869999766349792},{"id":"https://openalex.org/keywords/glucagon","display_name":"glucagon","score":0.4909999966621399},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9629999995231628},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.8450000286102295},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.6880000233650208},{"id":"https://openalex.org/keywords/energy-intake","display_name":"energy intake","score":0.6819999814033508},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7409999966621399},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.7730000019073486},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.5830000042915344},{"id":"https://openalex.org/keywords/homa","display_name":"HOMA","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.818949818611145},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.7666220664978027},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.7083187699317932},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5250610709190369},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49867963790893555},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4756600260734558},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4439881443977356},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2925773561000824},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2113206684589386},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.19189655780792236},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.1775922179222107},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.05840107798576355},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015992","descriptor_name":"Body Mass Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019518","descriptor_name":"Postprandial Period","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1111/j.1463-1326.2011.01428.x","doi":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2011.01428.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2265760","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3258427","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3258427","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3258427/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:21615670","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21615670","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.287.3273","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.287.3273","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/dc/ec/Diabetes_Obes_Metab_2011_Nov_13(11)_982-989.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1111/j.1463-1326.2011.01428.x","doi":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1463-1326.2011.01428.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2011.01428.x","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2028092672.pdf","grobid_xml":"https://content.openalex.org/works/W2028092672.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1910418518","https://openalex.org/W1966372003","https://openalex.org/W1973351394","https://openalex.org/W1994743271","https://openalex.org/W1996154084","https://openalex.org/W2013194198","https://openalex.org/W2032322539","https://openalex.org/W2054185381","https://openalex.org/W2084142744","https://openalex.org/W2085862152","https://openalex.org/W2101613382","https://openalex.org/W2105926302","https://openalex.org/W2114369760","https://openalex.org/W2115707749","https://openalex.org/W2124620553","https://openalex.org/W2126781806","https://openalex.org/W2140952918","https://openalex.org/W2148798434","https://openalex.org/W2153770190","https://openalex.org/W2155568871","https://openalex.org/W2159198773","https://openalex.org/W2171512247","https://openalex.org/W2344620176","https://openalex.org/W2634243099"],"related_works":["https://openalex.org/W2159198773","https://openalex.org/W1996154084","https://openalex.org/W2140952918","https://openalex.org/W2588441560","https://openalex.org/W1615542701","https://openalex.org/W2124224832","https://openalex.org/W2309324020","https://openalex.org/W2028272916"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"compare":[2],"exenatide":[3,42,86,146,162,186,203,213,221,262],"and":[4,7,57,121,126,135,139,214,242,274],"sitagliptin":[5,49,215],"glucose":[6,72,108,115,132,175],"glucoregulatory":[8],"measures":[9],"in":[10,245],"subjects":[11,25],"with":[12,131,161,202,220,247],"type":[13],"2":[14],"diabetes.":[15],"METHODS:":[16],"An":[17],"8-week,":[18],"double-blind,":[19],"randomized,":[20],"crossover,":[21],"single-centre":[22],"study.":[23],"Eighty-six":[24],"(58%":[26],"female,":[27],"body":[28],"mass":[29],"index":[30],"35":[31],"\u00b1":[32,38],"5":[33],"kg/m\u00b2,":[34],"haemoglobin":[35],"A1c":[36],"8.3":[37],"1.0%)":[39],"received":[40],"either":[41],"10":[43],"\u00b5g":[44],"(subcutaneous)":[45],"twice":[46],"daily":[47,53],"or":[48],"100":[50],"mg":[51],"(oral)":[52],"for":[54,63],"4":[55,66],"weeks":[56],"crossed":[58],"to":[59,100,176,240,254,260],"the":[60,74,112,128],"other":[61],"therapy":[62],"an":[64,255],"additional":[65],"weeks.":[67],"Main":[68],"outcome":[69],"was":[70,230],"time-averaged":[71],"during":[73,142],"24-h":[75,83,217,267],"inpatient":[76],"visits.":[77],"RESULTS:":[78],"Both":[79,103,155,170,192,212],"treatments":[80,104,156,171],"decreased":[81,105,157,172,216],"average":[82,266],"glucose,":[84,268],"but":[85,145],"had":[87,147],"a":[88,148,164,177,205,223],"greater":[89,150,165,207,224],"effect":[90,151,166,208,225],"[between-group":[91],"difference:":[92],"-0.67":[93],"mmol/l,":[94],"95%":[95],"confidence":[96],"interval":[97],"(CI):":[98],"-0.9":[99],"-0.4":[101],"mmol/l].":[102],"2-h":[106,269],"postprandial":[107,158,188],"(PPG),":[109],"area":[110],"under":[111],"curve":[113],"of":[114,198,233],"above":[116],"7.8":[117,136],"mmol/l":[118,123,137],"(140":[119],"mg/dl)":[120,125,141],"11":[122],"(200":[124],"increased":[127],"time":[129],"spent":[130],"between":[133],"3.9":[134],"(70":[138],"140":[140],"24":[143],"h,":[144],"significantly":[149,206,264],"(p":[152,167,180,209,226],"<":[153,168,227],"0.05).":[154],"serum":[159],"glucagon,":[160,271],"having":[163,204,222],"0.005).":[169,211],"fasting":[173],"blood":[174],"similar":[178],"degree":[179],"=":[181,210],"0.766).":[182],"Sitagliptin":[183],"increased,":[184],"while":[185],"decreased,":[187],"intact":[189],"glucagon-like":[190],"peptide-1.":[191],"drugs":[193],"improved":[194,275],"homeostasis":[195],"model":[196],"assessment":[197],"\u03b2-cell":[199],"function":[200],"(HOMA-B),":[201],"caloric":[218,272],"intake,":[219],"0.001).":[228],"There":[229],"no":[231],"episode":[232],"major":[234],"hypoglycaemia.":[235],"Adverse":[236],"events":[237],"were":[238,252],"mild":[239],"moderate":[241],"mostly":[243],"gastrointestinal":[244],"nature":[246],"exenatide.":[248],"No":[249],"study":[250],"withdrawals":[251],"due":[253],"adverse":[256],"event.":[257],"CONCLUSION:":[258],"Compared":[259],"sitagliptin,":[261],"showed":[263],"lower":[265],"PPG,":[270],"intake":[273],"HOMA-B.":[276]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2028092672","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
